ATE206759T1 - Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom - Google Patents

Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom

Info

Publication number
ATE206759T1
ATE206759T1 AT97933664T AT97933664T ATE206759T1 AT E206759 T1 ATE206759 T1 AT E206759T1 AT 97933664 T AT97933664 T AT 97933664T AT 97933664 T AT97933664 T AT 97933664T AT E206759 T1 ATE206759 T1 AT E206759T1
Authority
AT
Austria
Prior art keywords
melanoma
peptide analogues
associated peptide
vaccines against
ctl
Prior art date
Application number
AT97933664T
Other languages
English (en)
Inventor
Carl Gustav Figdor
Gosse Jan Adema
Original Assignee
Introgene Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Introgene Bv filed Critical Introgene Bv
Application granted granted Critical
Publication of ATE206759T1 publication Critical patent/ATE206759T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97933664T 1996-07-11 1997-07-08 Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom ATE206759T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201945 1996-07-11
PCT/EP1997/003712 WO1998002538A1 (en) 1996-07-11 1997-07-08 Melanoma associated peptide analogues and vaccines against melanoma

Publications (1)

Publication Number Publication Date
ATE206759T1 true ATE206759T1 (de) 2001-10-15

Family

ID=8224171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933664T ATE206759T1 (de) 1996-07-11 1997-07-08 Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom

Country Status (10)

Country Link
EP (1) EP0934405B1 (de)
JP (2) JP4386463B2 (de)
AT (1) ATE206759T1 (de)
AU (1) AU3693897A (de)
CA (1) CA2259944C (de)
DE (1) DE69707296T2 (de)
ES (1) ES2165619T3 (de)
ID (1) ID18726A (de)
WO (1) WO1998002538A1 (de)
ZA (1) ZA975858B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
US6326200B1 (en) * 1997-06-23 2001-12-04 Ludwig Institute For Cancer Research Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof
JP2003512829A (ja) 1999-10-22 2003-04-08 アヴェンティス パストゥール リミテッド 改変型ｇｐ１００およびその使用
JP2005503118A (ja) * 2001-02-14 2005-02-03 ジェンザイム・コーポレーション 改変ペプチドリガンド
EP2102236B1 (de) 2007-01-12 2014-08-06 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services GP100-spezifische T-Zellen-Rezeptoren sowie entsprechende Materialien und Verwendungsverfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE272113T1 (de) * 1994-02-16 2004-08-15 Crucell Holland Bv Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
WO1995029193A2 (en) * 1994-04-22 1995-11-02 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Melanoma antigens
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma

Also Published As

Publication number Publication date
WO1998002538A1 (en) 1998-01-22
DE69707296T2 (de) 2002-07-25
CA2259944C (en) 2011-06-28
ES2165619T3 (es) 2002-03-16
ID18726A (id) 1998-05-07
DE69707296D1 (de) 2001-11-15
EP0934405A1 (de) 1999-08-11
JP5198354B2 (ja) 2013-05-15
CA2259944A1 (en) 1998-01-22
JP2000515739A (ja) 2000-11-28
AU3693897A (en) 1998-02-09
JP4386463B2 (ja) 2009-12-16
EP0934405B1 (de) 2001-10-10
ZA975858B (en) 1998-09-01
JP2009178166A (ja) 2009-08-13

Similar Documents

Publication Publication Date Title
ATE272113T1 (de) Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
Roth et al. Immune response against tumors
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
CO4810234A1 (es) Vacunas para el tratamiento de virus papiloma humano
CY1114722T1 (el) Αντιγονα στρεπτοκοκκου
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
PT2092938E (pt) Péptidos derivados de survivina e a sua utilização
ATE206759T1 (de) Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
AU2003241127A8 (en) Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
WO2000069915A3 (en) COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
EP2193804A3 (de) Rekombinantes Adenylat-Cyclase-Toxin von Bordetella induziert T-Zell-Antworten gegen tumorale Antigene
ATE344052T1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
DE69714591D1 (de) Prostatakrebs- spezifischer antikörper für immundetektion und immuntherapie
NZ515332A (en) Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
SE8700466D0 (sv) Vaccines against melanoma
PT1560848E (pt) Péptido imunogénico de ptprk

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification